![]() | |
Supplier Name | MedChemExpress (MCE) |
Contact | sales |
Tel | 609-228-6898 |
Mobile | 609-228-6898 |
sales@medchemexpress.com; tech@medchemexpress.com | |
Website | https://www.medchemexpress.com/ |
Product Name | EV2-7 |
Synonyms | EV2-7 |
CAS | 138660-96-5 |
EINECS | |
Chemical Formula | |
Molecular Weight | |
inchi | |
Package | Inquiry |
Price | Get quote |
Descriptions | Sevirumab MedChemExpress (MCE) HY-P99900 MSL-109 Please store the product under the recommended conditions in the Certificate of Analysis. Sevirumab (MSL-109) is a human IgG1 neutralizing monoclonal antibody against cytomegalovirus (CMV). Sevirumab recognizes CMV gH complexes and inhibits CMV replication with an EC50 of 0.3 μg/mL. Sevirumab (MSL-109) perturbs the gH/gL homodimer rather than abolishing dimerization. Sevirumab may be splaying the dimer apart at sufficient distance to reduce fluorescence resonance energy transfer (FRET) and ultimately prevent proper gH/gL function[2]. EC50: 0.3 μg/mL (CMV)[1] In Vitro Sevirumab (MSL-109) perturbs the gH/gL homodimer rather than abolishing dimerization. Sevirumab may be splaying the dimer apart at sufficient distance to reduce fluorescence resonance energy transfer (FRET) and ultimately prevent proper gH/gL function[2]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> Sevirumab Related Antibodies Human Human IgG1 kappa Human IgG1 kappa, Isotype Control |
Supplier Website | https://www.medchemexpress.com/sevirumab.html |
Last Update | 2025-05-21 16:50:25 |